Patents Represented by Attorney James W. Williams, Jr.
  • Patent number: 4707491
    Abstract: .gamma.-Thiobutyrolactone derivatives having short chain .alpha.- and/or .gamma.-alkyl or alkenyl substituents have useful anticonvulsant properties.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: November 17, 1987
    Assignee: Washington University
    Inventors: Douglas F. Covey, Jeffrey A. Levine, James A. Ferrendelli
  • Patent number: 4704451
    Abstract: Novel tetradecapeptides having the following sequence were found to have potent mitogenic activity for machropage-like cells:H-Tyr-Pro-Pro-X-Asn-Lys-Asn-Phe-Thr-Glu-Asn-Asp-Leu-Leu-OH,wherein X=Trp or Tyr,or the physiologically acceptable salts, esters or amides thereof.
    Type: Grant
    Filed: October 15, 1985
    Date of Patent: November 3, 1987
    Assignee: Washington University
    Inventor: George D. Wilner
  • Patent number: 4704380
    Abstract: Novel tetradecapeptides having the following sequence were found to have potent mitogenic activity for machropage-like cells:H-Tyr-Pro-Pro-X-Asn-Lys-Asn-Phe-Thr-Glu-Asn-Asp-Leu-Leu-OH,wherein X=Trp or Tyr, or the physiologically acceptable salts, esters or amides thereof.
    Type: Grant
    Filed: January 7, 1987
    Date of Patent: November 3, 1987
    Assignee: Washington University
    Inventor: George D. Wilner
  • Patent number: 4687841
    Abstract: Novel peptide hydroxamic acid derivatives having useful collagenase inhibitory activity and capable of forming affinity resins for the purification of vertebrate collagenase are defined by the following structural formula:R-Pro-Leu-Gly-NHOHwherein R=H or N-protecting group or agarose.
    Type: Grant
    Filed: October 18, 1985
    Date of Patent: August 18, 1987
    Assignee: Monsanto Company
    Inventors: Curtis A. Spilburg, William McC. Moore
  • Patent number: 4677220
    Abstract: A regioselective process for the preparation of .alpha.-L-aspartyl-L-phenylalanine methyl ester is disclosed. A controlled aqueous coupling reaction between .beta.-methyl-L-aspartate-N-carboxyanhydride and L-phenylalanine produces the aspartyl methyl ester of .alpha.-L-aspartyl-L-phenylalanine which is subsequently hydrolyzed and selectively esterified without isolation. The hydrochloride salt of .alpha.-L-aspartyl-L-phenylalanine methyl ester, which is selectively precipitated from the esterification mixture, can be neutralized to .alpha.-L-aspartyl-L-phenylalanine methyl ester.
    Type: Grant
    Filed: October 31, 1985
    Date of Patent: June 30, 1987
    Assignee: Monsanto Company
    Inventors: Jacob S. Tou, Billy D. Vineyard
  • Patent number: 4672140
    Abstract: This disclosure concerns acyloxyhexenoic acids and their salts with the acids being produced by reaction of butadiene and acetic acid with metal salt oxidants in a process involving electrolytic regeneration of the metal oxidants during the reaction. Iosmeric acetoxyhexenoic acids produced can be readily converted to sorbic acid, and antimicrobial and preservative uses for the acids are also disclosed.
    Type: Grant
    Filed: November 23, 1981
    Date of Patent: June 9, 1987
    Assignee: Monsanto Company
    Inventors: James P. Coleman, Richard C. Hallcher, Dudley E. McMackins
  • Patent number: 4665021
    Abstract: The disclosure relates to an in vitro diagnostic method of screening for immune deficiency in a nephrotic patient comprising administering the presence or absence of the lymphokine, soluble immune response suppressor, in a urine sample of said patient.
    Type: Grant
    Filed: September 21, 1984
    Date of Patent: May 12, 1987
    Inventors: H. William Schnaper, Thomas M. Aune
  • Patent number: 4659659
    Abstract: A method is disclosed for the diagnosis of diseases having an arthritic component such as rheumatoid arthritis and osteoarthritis which comprises determining the deficiency of galactose in a sample of the patient's blood serum or plasma, or synovial fluid, or an Ig component or fragment thereof in comparison with the corresponding normal values of galactose.
    Type: Grant
    Filed: January 22, 1985
    Date of Patent: April 21, 1987
    Assignee: Monsanto Company
    Inventors: Raymond A. Dwek, Thomas W. Rademacher
  • Patent number: 4647350
    Abstract: Perfluoroalkanoic acids and perfluoroalkanols are prepared by electrolysis of perfluoroalkyl chlorides in the presence of carbon dioxide or an aldehyde, for example, trifluoroacetic acid is obtained from chlorotrifluoromethane and carbon dioxide while trifluoroethanol is obtained from chlorotrifluoromethane and formaldehyde.
    Type: Grant
    Filed: October 15, 1985
    Date of Patent: March 3, 1987
    Assignee: Monsanto Company
    Inventors: Richard C. Hallcher, Zane V. Zeable
  • Patent number: 4645829
    Abstract: A method of separating a first polypeptide fraction from a second polypeptide fraction of a mixed solution is disclosed. A predetermined charged polymer is admixed with the mixed solution preferably in the presence of a neutral polymer. The charged polymer interacts with the first fraction to form a precipitate. The neutral polymer enhances the effectiveness of the charged polymer in precipitating the first fraction. By proper selection of the polymer combination the desired polypeptide fraction can be precipitated from solution leaving the other polypeptide fraction in solution or vice versa.
    Type: Grant
    Filed: October 29, 1984
    Date of Patent: February 24, 1987
    Assignee: Monsanto Company
    Inventor: Sa Van Ho
  • Patent number: 4639422
    Abstract: Cell culture filter apparatus and method is disclosed for the large scale cultivation of mammalian cells. This system is adapted for convenient manual assembly - disassembly of internal parts and interchangeability of filtration units.
    Type: Grant
    Filed: February 3, 1986
    Date of Patent: January 27, 1987
    Assignee: Monsanto Company
    Inventors: Raymond C. Geimer, William R. Tolbert
  • Patent number: 4639468
    Abstract: A glycinamide derivative of the general formula I: ##STR1## wherein: R is a linear or ramified alkyl group C.sub.5 -C.sub.18, a linear or ramified alkenyl group C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9, C.sub.10, C.sub.11, C.sub.12, C.sub.13, C.sub.14, C.sub.15, C.sub.16, C.sub.17 or C.sub.18, a linear or ramified alkynyl group C.sub.4 -C.sub.10, a linear or ramified acyl group C.sub.4 -C.sub.18, a linear or ramified alkyl group C.sub.1 -C.sub.10, substituted by a phenoxy group, by a hydroxy radical, by an acetoxy radical, by a carboxy radical, by a linear or ramified alkoxycarbonyl group C.sub.1 -C.sub.4, by a carbonyl radical, by a carboxaldehyde group, by an acetal or cetal group, by one or more phenyl groups, by one or more phenyl groups substituted by a halogen atom such as fluorine, chlorine or bromine,R.sub.1 represents hydrogen, a linear or ramified alkyl group C.sub.1, C.sub.2, C.sub.3, C.sub.4, C.sub.5, C.sub.6, C.sub.7, C.sub.8, C.sub.9 or C.sub.10, a linear or ramified acyl group C.sub.1 -C.
    Type: Grant
    Filed: August 23, 1985
    Date of Patent: January 27, 1987
    Assignee: Continental Pharma Inc.
    Inventors: Romeo Roncucci, Claude L. Gillet, Alexis H. Cordi, Mark A. Martens, Joseph L. Roba, Paul J. Niebes, Georges E. Lambelin, William R. Van Dorsser
  • Patent number: 4601797
    Abstract: Hydroxyibuprofen is produced in good yield by reduction of p-isobutylacetophenone at the cathode in the presence of carbon dioxide. Hydroxyibuprofen is readily hydrogenolyzed to ibuprofen. Electrochemical carboxylation of other selected aryl methyl ketones is also effected.
    Type: Grant
    Filed: March 1, 1985
    Date of Patent: July 22, 1986
    Assignee: Monsanto Company
    Inventor: John H. Wagenknecht
  • Patent number: 4598162
    Abstract: Novel, liquid mixtures of isomeric aldehydes and alcohols are described in the C.sub.11 -C.sub.16 carbon range, the compounds being characterized by a main carbon branched at the position and moderate additional branching in most isomers; the aldehyde mixtures are prepared by an economic route from olefins involving oxo and aldol reaction with the reaction conducted in such a way as to give a high percentage of aldolable product, and preferably with a base catalyzed aldol reaction conducted under conditions to make high conversions attainable. The aldehyde mixtures can be hydrogenated to alcohols and converted to novel ethoxylates or sulfate compositions suitable for use as biodegradable detergents; or hydrogenated and oxidized to novel carboxylic acid compositions also suitable for detergent use.
    Type: Grant
    Filed: November 4, 1983
    Date of Patent: July 1, 1986
    Assignee: Monsanto Company
    Inventors: Denis Forster, George F. Schaefer, George E. Barker
  • Patent number: 4596675
    Abstract: The disclosure relates to novel synthetic thiopeptolide substrates having high activity for the enzyme collagenase. These substrates have the following amino acid sequences:R-Pro-X-Gly-S-Y-Z-Gly-R.sub.1whereinR=H or N-protecting group,X=Leu, Ile, Phe, Val, Gln, Ala,Y=Leu, Ile, Phe, Val, Ala,Z=Leu, Ile, Phe, Val, Gln, Ala, andR.sub.1 =terminal amide, carboxyl or ester group.
    Type: Grant
    Filed: September 25, 1985
    Date of Patent: June 24, 1986
    Assignee: Monsanto Company
    Inventors: Harold I. Weingarten, Joseph Feder
  • Patent number: 4585741
    Abstract: The vitamin D metabolite, calcitriol, is determined in blood serum by radioimmunoassay employing monoclonal antibodies in which calcitroic acid serves as the immunogen.
    Type: Grant
    Filed: August 25, 1983
    Date of Patent: April 29, 1986
    Inventors: Brian L. Clevinger, John G. Haddad, Steven L. Teitelbaum
  • Patent number: 4582650
    Abstract: Processes are given for which a microcrystalline support having a noble metal located within its pores, is used as a permselective catalyst to oxidize formaldehyde and similar materials while avoiding poisoning by N-phosphonomethylamines. The permselective catalyst can be used as a co-catalyst with activated carbons in the oxidation of N-phosphonomethyliminodiacetic acid to N-phosphonomethylglycine.
    Type: Grant
    Filed: February 11, 1985
    Date of Patent: April 15, 1986
    Assignee: Monsanto Company
    Inventor: Timothy R. Felthouse
  • Patent number: 4582577
    Abstract: Hydroxyibuprofen is produced in good yield by reduction of p-isobutylacetophenone at the cathode in the presence of carbon dioxide. Hydroxyibuprofen is readily hydrogenolyzed to ibuprofen.
    Type: Grant
    Filed: December 19, 1984
    Date of Patent: April 15, 1986
    Assignee: Monsanto Company
    Inventor: John H. Wagenknecht
  • Patent number: 4579962
    Abstract: Enhanced HMBA compositions which comprise 2-hydroxy-4-methylthiobutanoic acid and at least one metallic cation selected from the group consisting of sodium, potassium, magnesium and zinc ions are disclosed. The enhanced HMBA compositions are prepared by contacting HMBA and predetermined metallic cation(s) in molar ratios which are hyperstoichiometric and less than about five.
    Type: Grant
    Filed: February 24, 1984
    Date of Patent: April 1, 1986
    Assignee: Monsanto Company
    Inventor: Masaharu Takano
  • Patent number: 4569907
    Abstract: The disclosure relates to novel synthetic thiopeptolide substrates having high activity for the enzyme collagenase. These substrates have the following amino acid sequences:R-Pro-X-Gly-S-Y-Z-Gly-R.sub.1whereinR=H or N-protecting group,X=Leu, Ile, Phe, Val, Gln, Ala,Y=Leu, Ile, Phe, Val, Ala,Z=Leu, Ile, Phe, Val, Gln, Ala, andR.sub.1 =terminal amide, carboxyl or ester group.
    Type: Grant
    Filed: January 16, 1984
    Date of Patent: February 11, 1986
    Assignee: Monsanto Company
    Inventors: Harold I. Weingarten, Joseph Feder